InsidersTradesSigma
Discover the detailed record of transactions filed by Levine Mark S., Dirigeant. Officer active across 2 companies, notably Flexion Therapeutics Inc. In total, 6 disclosures have been recorded. Total volume traded: €43k. The latest transaction was disclosed on 28 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations
Mark S. Levine is General Counsel and Chief Legal Officer at Flexion Therapeutics Inc and Immunovant, Inc. He oversees the legal affairs of the companies and ensures compliance with applicable regulations.